Biotech Values

[DewDiligence]

Does anyone think that M118's potential has not been harmed, at least potentially, by the recent success of the oral agents…?

To date, none of the new oral anticoagulants has succeeded in ACS. Thus, the harm to M118 from these agents has not been the competition per se, but rather the removal of certain companies from the universe of MNTA’s prospective partners.